Follow the BioNTech SE stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €19.7bn. The latest transaction was reported on 9 September 2026 (Cession). Among the most active insiders: Sahin Ugur. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€18m
5 ops.
Sell Volume
33Σ signal
Buys n/a€18m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,050 of 29,064 companies
18.3
score / 100
Value
27
Quality
10
FCF yld-1.5%
Earn yld-5.0%
EV/EBITDA·
ROE-9.3%
Gross mgn2.7%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
858,209 shares@ US$103.810.39% mcap100.0% of flowAmerican Depositary Shares representing ordinary shares, no par value per shareSEC144:0002085929-26-000012